J.P. Morgan Upgrades Cabot (CBT) to Overweight
More News related to CBT
- Harvard Bioscience (HBIO) Appoints McNaughton New CFO
- HBIO Appoints McNaughton New CFO
- Cabot Corporation (CBT) Declares Quarterly Dividend
- Cabot Board Declares Dividend
- Loeb's Third Point 13F; Shows New Stakes in BUD, C, CVS, MER, WEN, UST, Sells Out of MA
More News related to Upgrades
- BMO Upgrades Spectrum Brands (SPC) to Market Perform
- Maxim Upgrades Palomar Medical (PMTI) to Buy
- RBC Capital Upgrades DSP Group (DSPG) to Sector Perform
- UBS Upgrades Morgans Hotel Group (MHGC) to Buy
- Janney Montgomery Scott Upgrades Wright Express Corp (WXS) to Buy.
J.P. Morgan upgrades Cabot (NYSE: CBT) from Neutral to Overweight.
Cabot Corporation (Cabot) is a global specialty chemicals and performance materials company.
Related Categories
UpgradesStocks Mentioned
+1.30Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
